Optimizing Combination Dabrafenib and Trametinib Therapy in BRAF Mutation-Positive Advanced Melanoma Patients: Guidelines From Australian Melanoma Medical Oncologists
Asia-Pacific Journal of Clinical Oncology - United Kingdom
doi 10.1111/ajco.12656
Full Text
Open PDFAbstract
Available in full text
Date
November 30, 2016
Authors
Publisher
Wiley